Abstract Edoxaban tosylate monohydrate (EDTM) is a direct oral anticoagulant drug that has recently been incorporated into most COVID-19 treatment protocols as either prophylaxis or therapy because it is effective and safe in the treatment of coagulopathy that is life-threatening in post-COVID-19. So, we developed a new, eco-friendly, sensitive differential pulse voltammetric method using 10.0% iron oxide nanoparticles as a modified carbon paste electrode (10.0% Fe₂O₃/CPE) in 0.1M borate buffer pH 10.0 as a supporting electrolyte. The electrochemical behavior of EDTM confirmed irreversible diffusion-controlled oxidation. Our modified sensor (10.0% Fe₂O₃/CPE) showed high sensitivity with a linear relationship between the peak current and EDTM concentration over the concentration range of 200–3500 ng/mL with a correlation coefficient of 0.9995, a limit of detection of 60 ng/mL, and a limit of quantification of 100 ng/mL. Our suggested method was successfully applied in bulk, pharmaceutical dosage form, spiked human plasma, and urine with high recovery 100.81% ±1.48 The results were statistically compared with the reported method and found to be in good agreement with it.
No takes yet. Share an insight, caveat, or question.
Rizk et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: